Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

DAC POWDER FOR INJECTION 200 mg/vial

Approval Number

SIN12499P

Drug Name

DAC POWDER FOR INJECTION 200 mg/vial

Product Name

DAC POWDER FOR INJECTION 200 mg/vial

Approval Date

January 10, 2004

Registrant

SHOEI UNIVERSAL CORPORATION PTE LTD

Licence Holder

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

Registrant

SHOEI UNIVERSAL CORPORATION PTE LTD

Licence Holder

SHOEI UNIVERSAL CORPORATION PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

L01AX04

ATC Item Name

dacarbazine

Manufacturer Information

Pharmaceutical Manufacturer

SHOEI UNIVERSAL CORPORATION PTE LTD

Manufacturers

DAE HAN NEW PHARM. CO. LTD.

Active Ingredients

Ingredient Name

DACARBAZINE

Strength

200 mg/vial

Drug MonographDacarbazine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

DAC POWDER FOR INJECTION 200 mg/vial - HSA Approval | MedPath